Beta-blockers: friend or foe in asthma? - Wikidata - awgldk - TriplyDB

Beta-blockers: friend or foe in asthma?

Beta-blockers: friend or foe in asthma?

http://www.wikidata.org/entity/Q37006857

about

Considerations of prescribers and pharmacists for the use of non-selective β-blockers in asthma and COPD patients: An explorative study.

P2860

Q48272068-95EDB660-FC07-4BDE-859B-596435C5FCD2

P2860

Beta-blockers: friend or foe in asthma?

http://www.wikidata.org/entity/Q37006857

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Beta-blockers: friend or foe in asthma?

@en

Beta-blockers: friend or foe in asthma?

@nl

type

label

Beta-blockers: friend or foe in asthma?

@en

Beta-blockers: friend or foe in asthma?

@nl

prefLabel

Beta-blockers: friend or foe in asthma?

@en

Beta-blockers: friend or foe in asthma?

@nl

P1433

Q37006857-2E4A1FD3-CF15-4A84-AD20-7F046D83FD81

P1476

Q37006857-1E2A194A-DFF2-4860-B301-C8A2188EA0C5

P2093

Q37006857-4A600564-8D12-48C1-BC48-64E3CA33BEEB

Q37006857-BFD258F8-A232-4470-BBA4-E22E9EC48FB2

P2860

Q37006857-0740B800-71BA-429E-97C7-165642954F6D

Q37006857-274F85A4-94AF-40DD-88BD-425F24855365

Q37006857-2B471C5C-E5EA-4A42-A5E0-6FBC88423263

Q37006857-2D9A30E4-E242-4859-BB21-B47AD2D134D5

Q37006857-32008EE5-FA4B-4499-8801-3351F15C5DC7

Q37006857-37288EA1-4834-494E-8BF7-562BE5E5A37B

Q37006857-58072CF8-01C9-4D78-B4CF-777529543DB5

Q37006857-64B8EFA5-D60D-4B09-8BE5-F193725366F0

Q37006857-67031B58-5FBE-4426-9F5E-9ECDD96D3012

Q37006857-763269BA-3EE2-4508-8BA9-A6E248C8524E

P304

Q37006857-7D7E9809-D47E-48A4-9609-3C5054CB949C

P31

Q37006857-E57D7976-D903-4241-8CA9-8AB230B6F861

P356

Q37006857-50861367-B8A1-4594-9A6C-8E2A15AE99DD

P407

Q37006857-75E6A76F-F8CA-462C-9A7C-F488F0053A4A

P478

Q37006857-2A735E5E-A95E-43CD-A0F5-FC3856B872E1

P577

Q37006857-C02EB0B8-E94B-4687-8D49-1FB5A092B55B

P698

Q37006857-4947F561-D9CD-4CDD-8F9B-94DF7CA5B1CE

P921

Q37006857-724B6549-7F8F-429E-BBF5-D25EA790551A

P932

Q37006857-D86CB32C-DCA9-4C4F-9879-9C0E6798780E

P356

P1433

International Journal of General Medicine

P1476

Beta-blockers: friend or foe in asthma?

@en

P2093

Bente Arboe

http://www.w3.org/2001/XMLSchema#string

Charlotte Suppli Ulrik

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and asthma: impact on severity, asthma control, and response to therapy

Cardioselective beta-blockers for reversible airway disease.

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Effects of hydrocortisone on acute β-adrenoceptor blocker and histamine induced bronchoconstriction.

The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model.

Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma

beta-Adrenoceptor inverse agonists in asthma

Evaluation of inhaled tiotropium in asthma, uncontrolled with standard combination therapy.

P304

549-555

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJGM.S46592

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23882156

http://www.w3.org/2001/XMLSchema#string

P921

P932

3709648

http://www.w3.org/2001/XMLSchema#string